Primary record
5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene
- 库存
- 5,722 克
- 纯度
- 98.7 %
- CAS
- 132539-06-1
化合物标识与属性
- CAS
- 132539-06-1
- PubChem CID
- 135398745
- SMILES
- CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C
- Canonical SMILES
- Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
名称与同义词
- olanzapine
- Zyprexa
- Olansek
- Zalasta
- Zyprexa Zydis
- 132539-06-1
- Zyprexa Velotab
- olanzapina
- Zypadhera
- Olzapin
- Symbyax
- Olanzapine Mylan
- Olazax
- Olanzapine Teva
- Olazax Disperzi
- olanzapinum
- Zyprexa Intramuscular
- Zolafren
- Lanzac
- Oferta
- Olanzapine cipla
- Olanzapin
- Olanzapine apotex
- Midax
- Olanzapine Glenmark
- Zydis
- Olanzapine-d3
- Arkolamyl
- Integrol
- Deprex
- Olanzapine Teva
- Olanzapine?
- Mixture Name
- Zolafren;
- Zyprexa Relprevv
- Zalasta;
- Zyprexa;
- Olanzapine CRS
- Olanzapine (OLA)
- Zyprexa Zydis;
- Olanzapine D3
- Olanzapine Neopharma
- Zyprexa (TN)
- Olanzapine pamoate
- olanzapine embonate
- Olanzapine solution
- Zolafren (TN)
- Olzapin (TN)
- Rexapin (TN)
- Zalasta (TN)
- Olanzapine [USAN:INN]
- Olanzapine Glenmark Europe
- Olanzapine (Zyprexa)
- Zydis (TN)
- PS15 - Olanzapine
- Olanzapine (Standard)
- LY-170053
- C17H20N4S
- N7U69T4SZR
- RefChem:6083
- CHEMBL715
- OLANZAPINE [MI]
- UNII-N7U69T4SZR
- AC1L1IHS
- OLANZAPINE [INN]
- OLANZAPINE [JAN]
- Lilly brand of olanzapine
- OLANZAPINE [USAN]
- LY 170053
- DTXSID9023388
- OLANZAPINE [VANDF]
- ACMC-209wx7
- D0V4QS
- GTPL47
- OLANZAPINE [MART.]
- CHEBI:7735
- DTXCID503388
- KVWDHTXUZHCGIO-UHFFFAOYSA-N
- OLANZAPINE [USP-RS]
- OLANZAPINE [WHO-DD]
- BIDD:PXR0138
- MFCD00866702
- SCHEMBL28763
- Olanzapine (JAN/USP/INN)
- Olanzapine pamoate monohydrate
- US8802672, Olanzapine
- ALKS-7921
- HSDB 8155
- KSC177A9B
- MLS000759457
- MLS001165781
- MLS001195646
- MLS001424057
- BIDD:GT0332
- Eli Lilly brand of olanzapine
- LY170053
- Olanzapine (JAN/USAN/INN)
- OLANZAPINE [EMA EPAR]
- SCHEMBL117695
- SPECTRUM1505024
- Olanzapine (LY-170053)
- 2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine
- LYBALVI COMPONENT OLANZAPINE
- Olanzapine [USAN:USP:INN:BAN]
- orb1308151
- 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
- Jsp001969
- OLANZAPINE [ORANGE BOOK]
- Olanzapine, >=98% (HPLC)
- SCHEMBL29358280
- BDBM35254
- BDBM82479
- CHEBI:94534
- CTK0H7090
- CTK6I2959
- ERK5-3E08
- KS-00000XJV
- 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
- AMY7709
- CID4585
- N05AH03
- OLANZAPINE [EP MONOGRAPH]
- Olanzapine CRS (Y0001370)
- GLXC-02527
- HMS2051H05
- HMS2089M04
- HMS2093I04
- HMS2233F24
- HMS3374L02
- HMS3393H05
- HMS3657I15
- HMS3714J03
- HMS3743A09
- HMS3884J21
- HMS5081A13
- OLANZAPINE [USP MONOGRAPH]
- SYMBYAX COMPONENT OLANZAPINE
- ACT03231
- ALBB-027265
- BCP04917
- EBD23216
- KS-1090
- LGB68679
- MSK10167
- NSC_4585
- Olanzapine, 1mg/ml in Acetonitrile
- ZINC3873830
- 10H-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-
- Tox21_111556
- AC-665
- ANW-46937
- C17-H20-N4-S
- CO0033
- EBC-06991
- HB1786
- HY-14541R
- NCGC00096077-03
- NP3393
- NSC754829
- NSC801187
- s2493
- STK634338
- STL388024
- ZINC52957434
- Olanzapine for system suitability CRS
- AKOS000282888
- AKOS005566122
- Olanzapine 1.0 mg/ml in Acetonitrile
- Tox21_111556_1
- ACN-029909
- AN-6960
- BCP9001021
- CCG-100922
- CS-1114
- CS-O-30992
- DB00334
- FO26537
- LY-170052
- NC00172
- NSC-754829
- NSC-801187
- NCGC00096077-01
- NCGC00096077-04
- NCGC00096077-05
- NCGC00096077-06
- NCGC00096077-18
- NCGC00096077-20
- NCGC00389791-02
- BC206213
- BR-57874
- CJ-20712
- CPD000466345
- HY-14541
- I960
- LY170052
- SAM001246652
- SC-16244
- SMR000466345
- Olanzapine ( 1.0 mg/mL in Acetonitrile)
- SBI-0206786.P001
- AB0013948
- AB1008596
- AJ-112146
- J489.991A
- LS-152313
- LY 170052
- RT-003566
- ST2417070
- TL8000772
- 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
- B2240
- CAS-132539-06-1
- CAS_132539-06-1
- FT-0673219
- NS00000036
- O0393
- SW220248-1
- A10667
- C07322
- D00454
- EN300-119499
- J10363
- S-4287
- 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
- AB00639907-06
- AB00639907-07
- AB00639907_08
- AB00639907_09
- 539O061
- A806453
- L000455
- L005958
- Q201872
- SR-01000759343
- 10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-
- A1200295
- I06-0784
- Olanzapine for System Suitability CRS (Y0001380)
- SR-01000759343-4
- SR-01000759343-6
- BRD-K18895904-001-15-3
- BRD-K18895904-001-16-1
- BRD-K18895904-001-17-9
- 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene
- Z1521553472
- Olanzapine, European Pharmacopoeia (EP) Reference Standard
- 2-Methyl-4-(4-methyl-1-piperazinyl)- 10H-thieno[2,3-b][1,5]benzodiazepine
- 2-methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[3,2-c][1,5]benzodiazepine
- 2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
- 786686-79-1
- Olanzapine, United States Pharmacopeia (USP) Reference Standard
- LY-170052, LY170052, LY 170052, Olanzapine, Zyprexa, Zolafren
- Olanzapine, Pharmaceutical Secondary Standard; Certified Reference Material
- 10H-tieno [2,3-b] [1,5 benzodiazepina], 2-metil-4-(4-metil-1-piperacinil)-
- 2-Methyl-10-(4-methyl-piperazin-1-yl)-4H-3-thia-4,9-diaza-benzo[f]azulene
- 2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
- 2-methyl-4-(4-methyl-1-piperazinyl)-10 H-thieno[2,3-b ] [1,5]benzodiazepine
- 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine
- 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine #
- 2-Methyl-4-(4-methylpiperazin-1-yl)-10H- thieno[2,3-b][1,5]benzodiazepin
- 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno(2,3-b)(1,5)benzodiazepine
- 2-methyl-4-(4-methylpiperazin-1-yl)-5H-benzo[b]thieno[2,3-e][1,4]diazepine
- 5h-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-
- Olanzapine for system suitability, European Pharmacopoeia (EP) Reference Standard
- Olanzapine-d8, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material
- 1168-00-9
- 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Lanzac; Zyprexa
- 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo(8.4.0.03,7)tetradeca-1(14),3(7),5,8,10,12-hexaene
- 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0(3),?]tetradeca-1(14),3(7),5,8,10,12-hexaene
- 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0,3,7]tetradeca-1(10),3(7),5,8,11,13-hexaene
- 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),2,5,7,11,13-hexaene
- 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),5,8,10,12-hexaene
- 57-88-5
- Olanzapine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material
- Olanzapine, 99%, a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist - 1g 1g
- Olanzapine; 132539-06-1; Zyprexa; Zyprexa Zydis; Olansek; Zalasta; Zyprexa Intramuscular; Zyprexa Velotab;
- Olanzapine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; LY 170053; Lanzac; Zyprexa
- OZP